Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2012 1
2016 1
2017 4
2018 1
2019 6
2020 11
2021 19
2022 19
2023 9
2024 5
2025 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Results by year

Filters applied: . Clear all
Page 1
Tolebrutinib in Nonrelapsing Secondary Progressive Multiple Sclerosis.
Fox RJ, Bar-Or A, Traboulsee A, Oreja-Guevara C, Giovannoni G, Vermersch P, Syed S, Li Y, Vargas WS, Turner TJ, Wallstroem E, Reich DS; HERCULES Trial Group. Fox RJ, et al. N Engl J Med. 2025 May 15;392(19):1883-1892. doi: 10.1056/NEJMoa2415988. Epub 2025 Apr 8. N Engl J Med. 2025. PMID: 40202696 Clinical Trial.
A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.
Amarenco P, Kim JS, Labreuche J, Charles H, Abtan J, Béjot Y, Cabrejo L, Cha JK, Ducrocq G, Giroud M, Guidoux C, Hobeanu C, Kim YJ, Lapergue B, Lavallée PC, Lee BC, Lee KB, Leys D, Mahagne MH, Meseguer E, Nighoghossian N, Pico F, Samson Y, Sibon I, Steg PG, Sung SM, Touboul PJ, Touzé E, Varenne O, Vicaut É, Yelles N, Bruckert E; Treat Stroke to Target Investigators. Amarenco P, et al. N Engl J Med. 2020 Jan 2;382(1):9. doi: 10.1056/NEJMoa1910355. Epub 2019 Nov 18. N Engl J Med. 2020. PMID: 31738483 Clinical Trial.
Intracranial Hemorrhage in the TST Trial.
Amarenco P, Kim JS, Labreuche J, Charles H, Giroud M, Lavallée PC, Lee BC, Mahagne MH, Meseguer E, Nighoghossian N, Steg PG, Vicaut É, Bruckert E; Treat Stroke to Target Investigators*. Amarenco P, et al. Stroke. 2022 Feb;53(2):457-462. doi: 10.1161/STROKEAHA.121.035846. Epub 2021 Dec 29. Stroke. 2022. PMID: 34963300 Clinical Trial.
Sex-Related Gap in the Use of Disease-Modifying Therapies in Multiple Sclerosis.
Gavoille A, Leray E, Marignier R, Rollot F, Casey R, Mathey G, Michel L, De Seze J, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Laplaud DA, Papeix C, Defer G, Moreau T, Berger E, Dubessy AL, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Camdessanche JP, Doghri I, Moulin S, Labeyrie C, Hankiewicz K, Dos Santos A, Pottier C, Manchon E, Tchikviladze M, Lebrun-Frenay C, Vukusic S; OFSEP investigators. Gavoille A, et al. Among authors: manchon e. Neurology. 2025 Aug 26;105(4):e213907. doi: 10.1212/WNL.0000000000213907. Epub 2025 Jul 30. Neurology. 2025. PMID: 40737571
Target trial emulation to replicate randomised clinical trials using registry data in multiple sclerosis.
Gavoille A, Nourredine M, Rollot F, Casey R, Mathey G, Kerbrat A, Ciron J, De Sèze J, Stankoff B, Maillart E, Ruet A, Labauge P, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al Khedr A, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanché JP, Doghri I, Sarov M, Hankiewicz K, Pottier C, Dos Santos A, Manchon E, Tchikviladze M, Rabilloud M, Subtil F, Vukusic S. Gavoille A, et al. Among authors: manchon e. J Neurol Neurosurg Psychiatry. 2025 Sep 4:jnnp-2025-336762. doi: 10.1136/jnnp-2025-336762. Online ahead of print. J Neurol Neurosurg Psychiatry. 2025. PMID: 40908119 Free article.
Use of Disease-Modifying Therapies in Patients With Late-Onset Multiple Sclerosis.
Robin C, Rollot F, Lefort M, Casey R, Vukusic S, Mathey G, Ciron J, De Seze J, Stankoff B, Maillart E, Ruet A, Labauge PM, Kwiatkowski A, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Laplaud DA, Berger E, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Casez O, Bourre B, Wahab A, Magy L, Moulin S, Camdessanche JP, Doghri I, Sarov M, Hankiewicz K, Pottier C, Dos Santos A, Manchon E, Tchikviladze M, Nifle C, Kerbrat A, Edan G, Le Page E, Michel L; as the OFSEP Investigators. Robin C, et al. Among authors: manchon e. Neurology. 2025 Aug 12;105(3):e213744. doi: 10.1212/WNL.0000000000213744. Epub 2025 Jul 16. Neurology. 2025. PMID: 40669026
Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
Gavoille A, Rollot F, Casey R, Kerbrat A, Le Page E, Bigaut K, Mathey G, Michel L, Ciron J, Ruet A, Maillart E, Labauge P, Zephir H, Papeix C, Defer G, Lebrun-Frenay C, Moreau T, Berger E, Stankoff B, Clavelou P, Thouvenot E, Heinzlef O, Pelletier J, Al-Khedr A, Casez O, Bourre B, Cabre P, Wahab A, Magy L, Camdessanché JP, Doghri I, Moulin S, Ben-Nasr H, Labeyrie C, Hankiewicz K, Neau JP, Pottier C, Nifle C, Manchon E, Lapergue B, Wiertlewski S, De Sèze J, Vukusic S, Laplaud DA; OFSEP Investigators. Gavoille A, et al. Among authors: manchon e. JAMA Neurol. 2024 Aug 1;81(8):814-823. doi: 10.1001/jamaneurol.2024.1961. JAMA Neurol. 2024. PMID: 38949816 Free PMC article.
71 results